Steve Lopez - Viveve Medical Director - Operations
| VIVEDelisted Stock | USD 0.1 0.0005 0.53% |
Director
Mr. Steve Lopez is Director of Operations of Viveve Medical, Inc. Steve joined Viveve in April 2009. He brings over 20 years of engineering, manufacturing, quality and operational experience supporting asthma, cardiovascular, esophageal, oncology, and surgical products, both in early stage and Fortune 500 companies. More recently, Steve worked at Asthmatx as the Director of Operations where he led the transition from RD assembly into clinical manufacturing along with managing scaleup activities for commercial release. Steve has held various leadership and technical roles at BRRX Medical, Boston Scientific, RadioTherapeutics, Johnson Johnson, and Guidant . Steve earned his M.S. degree in Engineering Management from California State University, Northridge, received his B.S. degree in Engineering from California State Polytechnic University, Pomona, and is a Certified Manufacturing Engineer. since 2014.
| Tenure | 10 years |
| Phone | 720 696 8100 |
| Web | https://www.viveve.com |
Viveve Medical Management Efficiency
The company has return on total asset (ROA) of (0.6213) % which means that it has lost $0.6213 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1099) %, meaning that it created substantial loss on money invested by shareholders. Viveve Medical's management efficiency ratios could be used to measure how well Viveve Medical manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 5.12 M in liabilities with Debt to Equity (D/E) ratio of 1.12, which is about average as compared to similar companies. Viveve Medical has a current ratio of 1.29, suggesting that it may not have the ability to pay its financial obligations when due. Debt can assist Viveve Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Viveve Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viveve Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viveve to invest in growth at high rates of return. When we think about Viveve Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Bret Hankey | Bone Biologics Corp | 39 | |
| Jane Emerson | Biomerica | 63 | |
| Allen Barbieri | Biomerica | 66 | |
| Michael Bator | Cytosorbents Crp | N/A | |
| Thomas Griffin | Helius Medical Technologies | 52 | |
| Benjamin Wu | Bone Biologics Corp | 53 | |
| Blane Walter | Helius Medical Technologies | 45 | |
| Martin Goldstein | NanoVibronix | 45 | |
| Savio Chiu | Helius Medical Technologies | 31 | |
| Edward Straw | Helius Medical Technologies | 76 | |
| Thomas Mika | NanoVibronix | 64 | |
| Huaizheng Peng | Helius Medical Technologies | 53 | |
| Mitch Tyler | Helius Medical Technologies | 62 | |
| Edward Jones | Cytosorbents Crp | 65 | |
| Janet Moore | Biomerica | 66 | |
| William Coffin | Bone Biologics Corp | 69 | |
| Chia Soo | Bone Biologics Corp | 47 | |
| Michael Mashaal | ReShape Lifesciences | 42 | |
| Alan Sobel | Cytosorbents Crp | 53 | |
| Jimmy Delshad | Bone Biologics Corp | 74 | |
| Gary Blackford | ReShape Lifesciences | 60 | |
Management Performance
| Return On Equity | -2.11 | ||||
| Return On Asset | -0.62 |
Viveve Medical Leadership Team
Elected by the shareholders, the Viveve Medical's board of directors comprises two types of representatives: Viveve Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Viveve. The board's role is to monitor Viveve Medical's management team and ensure that shareholders' interests are well served. Viveve Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Viveve Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jim Robbins, Principal Financial Officer | ||
| Martin PE, Dev Research | ||
| Suzon Lommel, VP Affairs | ||
| Debora Jorn, Director | ||
| Scott Durbin, CEO Director | ||
| Lori Bush, Director | ||
| Jon Plexico, Director | ||
| Brigitte Smith, Chairman of the Board | ||
| Karen Zaderej, Director | ||
| James Atkinson, Chief Business Officer and President | ||
| Steven Basta, Director | ||
| Lori McMillan, VP HR | ||
| Daniel Janney, Independent Director | ||
| Deborah MBA, Advisor Director | ||
| Jeannie Swindle, Sr Communications | ||
| Patricia Scheller, CEO, Director | ||
| Alan Curtis, Vice President - Regulatory, Clinical and Quality | ||
| Gary Kaiser, VP Marketing | ||
| Arlene Morris, Director | ||
| Steve Lopez, Director - Operations | ||
| Jeff Sinclair, VP Sales |
Viveve Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Viveve Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.11 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (3.10) % | ||||
| Current Valuation | 4.26 M | ||||
| Shares Outstanding | 10.72 M | ||||
| Shares Owned By Institutions | 5.21 % | ||||
| Number Of Shares Shorted | 374.24 K | ||||
| Price To Earning | (2.59) X | ||||
| Price To Book | 3.62 X | ||||
| Price To Sales | 0.66 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Viveve Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Viveve Medical's short interest history, or implied volatility extrapolated from Viveve Medical options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Viveve Pink Sheet
If you are still planning to invest in Viveve Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viveve Medical's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |